Getein Biotech Inc
603387StockSHG
8.14 ▲ +2.01%
12 juin 2026
6
Getein Biotech Inc
8.14 ▲ +2.01%
12 juin 2026
603387StockSHG

01 / À propos

Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. The company provides point-of-care detection, chemiluminescence detection, biochemical analysis, molecular testing, thrombus and hemostasis detection, blood cell analysis detection, urine analysis, quality control products, diagnostic raw materials, biochemical immunity, and other fields, such as myocardium, inflammation, renal function, thyroid function, hormones, glucose metabolism, tumor, coagulation, blood cells detection. The company was founded in 2002 and is headquartered in Nanjing, China.

Arberion
Loading market data